Evaluating the implementation of the UK's AMR Strategy
I am part of the PIRU team that has
been commissioned to undertake an evaluation of the UK Anti-Microbial
Resistance (AMR) Strategy, 2013-18. The first stage of the evaluation is a
scoping study to develop the questions, objectives and methods for the
evaluation, and to identify the data and evidence sources to be used. The
Strategy is very broad, containing many potentially interacting actions across
many sectors, including human and animal health, and with an international
dimension. A conventional evaluation of the impact of the Strategy, as would be
appropriate to a single intervention, is not possible. Instead, the evaluation
will comprise a study of the implementation of the Strategy and the key
mechanisms of change identified in the Strategy, with a view to helping
strengthen the Strategy in future.
A report from the scoping study,
and model describing the underlying logic of the Strategy, will be produced by
the end of 2016.
More information available here.